Healthcare provider profile · identity verified

David L. Byron, M.D.

Family Practice · HUTCHINSON, MN · NPI 1508942186

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	559	108
Furosemide	Furosemide	458	36
Amlodipine Besylate	Amlodipine Besylate	402	90
Metoprolol Succinate	Metoprolol Succinate	390	81
Losartan Potassium	Losartan Potassium	388	87
Omeprazole	Omeprazole	362	69
Gabapentin	Gabapentin	310	41
Levothyroxine Sodium	Levothyroxine Sodium	296	57
Lisinopril	Lisinopril	282	65
Rosuvastatin Calcium	Rosuvastatin Calcium	228	55
Warfarin Sodium	Warfarin Sodium	219	31
Simvastatin	Simvastatin	210	49
Trazodone Hcl	Trazodone Hcl	185	26
Tamsulosin Hcl	Tamsulosin Hcl	174	46
Pantoprazole Sodium	Pantoprazole Sodium	173	37
Metoprolol Tartrate	Metoprolol Tartrate	164	36
Tramadol Hcl	Tramadol Hcl	154	26
Hydrochlorothiazide	Hydrochlorothiazide	144	27
Metformin Hcl	Metformin Hcl	143	41
Allopurinol	Allopurinol	136	34
Potassium Chloride	Potassium Chloride	130	27
Eliquis	Apixaban	128	18
Metformin Hcl Er	Metformin Hcl	128	25
Clopidogrel	Clopidogrel Bisulfate	120	21
Memantine Hcl	Memantine Hcl	114	suppressed
Carvedilol	Carvedilol	110	21
Donepezil Hcl	Donepezil Hcl	105	14
Duloxetine Hcl	Duloxetine Hcl	104	suppressed
Mirtazapine	Mirtazapine	94	18
Escitalopram Oxalate	Escitalopram Oxalate	91	13
Fluticasone Propionate	Fluticasone Propionate	90	26
Prednisone	Prednisone	88	21
Spironolactone	Spironolactone	85	19
Citalopram Hbr	Citalopram Hydrobromide	83	18
Albuterol Sulfate Hfa	Albuterol Sulfate	78	26
Pravastatin Sodium	Pravastatin Sodium	74	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	72	19
Glipizide	Glipizide	70	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	66	18
Torsemide	Torsemide	66	19
Fluoxetine Hcl	Fluoxetine Hcl	63	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	53	suppressed
Sertraline Hcl	Sertraline Hcl	53	14
Propranolol Hcl	Propranolol Hcl	48	suppressed
Lorazepam	Lorazepam	47	15
Ozempic	Semaglutide	47	suppressed
Alendronate Sodium	Alendronate Sodium	46	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	46	28
Oxycodone Hcl	Oxycodone Hcl	45	11
Famotidine	Famotidine	44	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	43	suppressed
Finasteride	Finasteride	43	13
Paroxetine Hcl	Paroxetine Hcl	41	14
Carbidopa-Levodopa	Carbidopa/Levodopa	38	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	suppressed
Montelukast Sodium	Montelukast Sodium	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Xarelto	Rivaroxaban	33	11
Nystatin	Nystatin	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	31	suppressed
Insulin Aspart Flexpen	Insulin Aspart	30	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	11
Glipizide Er	Glipizide	27	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Ondansetron Odt	Ondansetron	27	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	25	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	24	11
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	22	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Glimepiride	Glimepiride	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Jantoven	Warfarin Sodium	21	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Methotrexate	Methotrexate Sodium	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Atenolol	Atenolol	19	suppressed
Cephalexin	Cephalexin	19	12
Latanoprost	Latanoprost	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Amoxicillin	Amoxicillin	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Fentanyl	Fentanyl	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Repatha Sureclick	Evolocumab	17	suppressed
Estradiol	Estradiol	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Diazepam	Diazepam	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Nitroglycerin	Nitroglycerin	14	12
Nyamyc	Nystatin	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	11
Desmopressin Acetate	Desmopressin Acetate	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Imiquimod	Imiquimod	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Temazepam	Temazepam	13	suppressed
Topiramate	Topiramate	13	suppressed
Baclofen	Baclofen	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Dupixent Pen	Dupilumab	12	suppressed
Leflunomide	Leflunomide	12	suppressed
Minocycline Hcl	Minocycline Hcl	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Budesonide Dr	Budesonide	11	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Tiadylt Er	Diltiazem Hcl	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error